The contracts were awarded by a major pharmaceutical company and an academic institution. These recurring customers have chosen Inhalation Sciences to ensure the uninterrupted operation of their inhalation research. By providing comprehensive preventative maintenance as part of the service contracts, Inhalation Sciences guarantees minimal downtime and timely completion of critical experiments.

"We are delighted to continue our strong partnership with these esteemed customers," said Manoush Masarrat, CEO of Inhalation Sciences. "Our technical service contracts are designed to provide operational efficiency. By offering reliable and timely maintenance, we empower our customers to focus on their core research objectives and achieve groundbreaking results in the field of inhalation delivery."

Inhalation Sciences specializes in supporting research and development in the inhalation drug delivery field. The company offers a wide range of services, including formulation development, preclinical studies, and clinical trial support. With a focus on delivering innovative solutions, Inhalation Sciences helps clients bring life-saving inhalation therapies to market.

For more information about Inhalation Sciences, please contact:

Manoush Masarrat, CEO

E-mail: Manoush.masarrat@inhalation.se

Mobile: +46 (0)73 628 9153

About Inhalation Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale® and DissolvIt® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, and so our health, when being inhaled.